Combination of KRAS ASO and RIG-I agonist in extracellular vesicles transforms the tumor microenvironment towards effective treatment of KRAS-dependent cancers
Theranostics · 2025
DOI: 10.7150/thno.105519 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2025. Verfasst von Cao Dai Phung und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Institute for Digital Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. Hauptthemen laut MEDLINE: Tumor Microenvironment, Proto-Oncogene Proteins p21(ras), Extracellular Vesicles, DEAD Box Protein 58. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Institute for Digital Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
- Vingroup Science and Technology Scholarship Program, Vin University, Hanoi, Vietnam.
- Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore.
- Institute of Structural Biology, Nanyang Technological University, Singapore.
- Synthetic Biology Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
- Cell Fate Engineering and Therapeutics Laboratory, A*STAR Institute of Molecular and Cell Biology, Singapore, 138673, Singapore.
Zitieren
APA
Phung, C. D., Tran, T. T. T., Yeo, B. Z. J., Prajogo, R. C., Saudjana, E., Yeo, E. Y. M., Gao, C., Nguyen, P. H. D., Jayasinghe, M. K., Dang, X. T. T., Lixuan, C. P., Nguyen, T. M., Peng, B., Le, A. H., Nguyen, T. T. T., Chan, G. M. E., Loh, Y. H., Goh, B. C., Tam, W. L., …, & Le, M. T. N. (2025). Combination of KRAS ASO and RIG-I agonist in extracellular vesicles transforms the tumor microenvironment towards effective treatment of KRAS-dependent cancers. Theranostics. https://doi.org/10.7150/thno.105519
Vancouver
Phung CD, Tran TTT, Yeo BZJ, Prajogo RC, Saudjana E, Yeo EYM, et al. Combination of KRAS ASO and RIG-I agonist in extracellular vesicles transforms the tumor microenvironment towards effective treatment of KRAS-dependent cancers. Theranostics. 2025. doi:10.7150/thno.105519
BibTeX
@article{Phung2025,
author = {Phung, Cao Dai and Tran, Trinh T T and Yeo, Brendon Zhi Jie and Prajogo, Rebecca Carissa and Saudjana, Evelyn and Yeo, Eric Yew Meng and Gao, Chang and Nguyen, Phuong H D and Jayasinghe, Migara Kavishka and Dang, Xuan T T and Lixuan, Celest Phang and Nguyen, Trinh Mai and Peng, Boya and Le, Anh Hong and Nguyen, Tram T T and Chan, Gloria Mei En and Loh, Yuin-Han and Goh, Boon Cher and Tam, Wai Leong and Bonney, Glenn Kunnath and Luo, Dahai and Le, Minh T N},
title = {Combination of KRAS ASO and RIG-I agonist in extracellular vesicles transforms the tumor microenvironment towards effective treatment of KRAS-dependent cancers},
journal = {Theranostics},
year = {2025},
doi = {10.7150/thno.105519}
}
EUVIMED